HotHouse Therapeutics emerges from stealth with £3m pre-seed led by SynBioVen to develop plant-based drug compounds

HotHouse Therapeutics develops plant-based methods for producing pharmaceutical compounds, using AI and bioengineering to create scalable alternatives to scarce natural ingredients in drug and vaccine supply chains.